Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Aita, Megumi ^a,b   Byers, Margaret R ^b   Chavkin, Charles ^a,b   Xu, Mei ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAPPA OPIATE RECEPTOR; BIOLOGICAL MARKER; BROXURIDINE; CD11 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE FILAMENT PROTEIN; NERVE PROTEIN; NESTIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CRANIAL NERVE INJURY; INFRAORBITAL NERVE; MALE; MICROGLIA; MOUSE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEM CELL; TRIGEMINAL NERVE; TRIGEMINUS GANGLION; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; GLIA; GLIOSIS; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIGATION; MACROPHAGE; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; TRIGEMINAL NERVE DISEASE; TRIGEMINAL NUCLEUS;

ANIMALS; ANTIGENS, CD11; ASTROCYTES; BIOLOGICAL MARKERS; BROMODEOXYURIDINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; LIGATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NERVE TISSUE PROTEINS; NEUROGLIA; RECEPTORS, OPIOID, KAPPA; TRIGEMINAL GANGLION; TRIGEMINAL NERVE DISEASES; TRIGEMINAL NUCLEI;

EID: 77349119625     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-6-8     Document Type: Article

References (48)

1. Cheshire WP. Trigeminal neuralgia: for one nerve a multitude of treatments. Expert Rev Neurother 2007, 7:1565-1579. 10.1586/14737175.7.11.1565, 17997704.
2. Xu M, Aita M, Chavkin C. Partial infraorbital nerve ligation as a model of trigeminal nerve injury in the mouse: behavioral, neural, and glial reactions. J Pain 2008, 9:1036-1048. 10.1016/j.jpain.2008.06.006, 2632609, 18708302.
3. Xu M, Petraschka M, McLaughlin JP, Westenbroek RE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, Terman GW, Chavkin C. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci 2004, 24:4576-4584. 10.1523/JNEUROSCI.5552-03.2004, 2376823, 15140929.
4. Toma J, McPhail LT, Ramer MS. Comparative postnatal development of spinal, trigeminal and vagal sensory root entry zones. Int J Devel Neurosci 2006, 24:373-388.
5. Jannetta PJ, Abbasy M, Maroon JC, Ramos FM, Albin MS. Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients. J Neurosurg 1977, 47:321-8. 10.3171/jns.1977.47.3.0321, 894338.
6. McLaughlin MR, Jannetta PJ, Clyde BL, Subach BR, Comey CH, Resnick DK. Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg 1999, 91:1-8.
7. Li ST, Wang X, Pan Q, Hai J, Liu N, Shen F, Liu Z, Guan Y. Studies on the operative outcomes and mechanisms of microvascular decompression in treating typical and atypical trigeminal neuralgia. Clin J Pain 2005, 21:311-316. 10.1097/01.ajp.0000120790.69705.5b, 15951648.
8. Henson CF, Goldman HW, Rosenwasser RH, Downes MB, Bednarz G, Pequignot EC, Werner-Wasik M, Curran WJ, Andrews DW. Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution. Int J Radiat Oncol Biol Phys 2005, 63:82-90. 16111575.
9. McNatt SA, Gonzalez-Gomez I, Nelson MD, McComb JG. Gamma knife radiosurgery for trigeminal neuralgia. Neurology 2005, 56:1295-1303.
10. Xu M, Bruchas MR, Ippolito DL, Gendron L, Chavkin C. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. J Neurosci 2007, 27:2570-2581. 10.1523/JNEUROSCI.3728-06.2007, 2104780, 17344394.
11. Bryant HU, Roudebush RE. Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J Pharmacol Exp Ther 1990, 255:410-4.
12. Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmumol 1998, 83:36-44.
13. Machelska H, Cabot PJ, Mousa SA, Zhang Q, Stein C. Pain control in inflammation governed by selectins. Nat Med 1998, 4:1425-1428. 10.1038/4017, 9846582.
14. Schmidt BL, Tambeli CH, Levine JD, Gear RW. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur J Neurosci 2002, 15:861-868. 10.1046/j.1460-9568.2002.01915.x, 11906528.
15. McLaughlin JP, Myers LC, Zarek PE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, Chavkin C. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem 2004, 279:1810-1818. 10.1074/jbc.M305796200, 2131729, 14597630.
16. McLaughlin JP, Xu M, Mackie K, Chavkin C. Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization. J Biol Chem 2003, 278:34631-40. 10.1074/jbc.M304022200, 12815037.
17. Bae YC, Nakagawa S, Yoshida A, Nagase Y, Takemura M, Shigenaga Y. Morphology and synaptic connections of slowly adapting periodontal afferent terminals in the trigeminal subnuclei principalis and oralis of the cat. J Comp Neurol 1994, 348:121-132. 10.1002/cne.903480107, 7814681.
18. Kim YS, Paik SK, Cho YS, Shin HS, Bae JY, Moritani M, Yoshida A, Ahn DK, Valtschanoff J, Hwang SJ, Moon C, Bae YC. Expression of P2X3 receptor in the trigeminal sensory nuclei of the rat. J Comp Neurol 2008, 506:627-39. 10.1002/cne.21544, 18067147.
19. Gray CW, Patel AJ. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction. Brain Res 1995, 691:169-179. 10.1016/0006-8993(95)00669-H, 8590049.
20. Araque A, Parpura V, Sanzgiri RP, Haydon PG. Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. Eur J Neurosci 1998, 10:2129-2142. 10.1046/j.1460-9568.1998.00221.x, 9753099.
21. Schwartz JP, Nishiyama N. Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res Bull 1994, 35:403-407. 10.1016/0361-9230(94)90151-1, 7532097.
22. Liu L, Rudin M, Kozlova EN. Glial cell proliferation in the spinal cord after dorsal rhizotomy or sciatic nerve transection in the adult rat. Exp Brain Res 2000, 131:64-73. 10.1007/s002219900273, 10759172.
23. Narita M, Yoshida T, Nakajima M, Narita M, Miyatake M, Takagi T, Yajima Y, Suzuki T. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem 2006, 97:1337-1348. 10.1111/j.1471-4159.2006.03808.x, 16606373.
24. Echeverry S, Shi XQ, Zhang J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 2008, 135:37-47. 10.1016/j.pain.2007.05.002, 17560721.
25. Thomas GA. Quantitative histology of Wallerian degeneration: II. Nuclear population in two nerves of different fibre spectrum. J Anat 1948, 82:135-145.
26. Hu P, Bembrick AL, Keay KA, McLachlan EM. Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve. Brain Behav Immun 2007, 21:599-616. 10.1016/j.bbi.2006.10.013, 17187959.
27. Scherer SS, Salzer J. Axon-Schwann cell interaction during peripheral nerve degeneration and regeneration, Glial Cell Development. 2003, 299-330. Oxford University Press, London.
28. Banner LR, Patterson PH. Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc Natl Acad Sci USA 1994, 91:7109-13. 10.1073/pnas.91.15.7109, 44348, 8041754.
29. Bolin LM, Verity AN, Silver JE, Shooter EM, Abrams JS. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995, 64:850-858.
30. Siebert H, Sachse A, Kuziel WA, Maeda N, Bruck W. The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol 2000, 110:177-185. 10.1016/S0165-5728(00)00343-X, 11024548.
31. Toews AD, Barrett C, Morell P. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve. J Neurosci Res 1998, 53:260-267. 10.1002/(SICI)1097-4547(19980715)53:2<260::AID-JNR15>3.0.CO;2-A, 9671983.
32. Tofaris GK, Patterson PH, Jessen KR, Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci 2002, 22:6696-6703.
33. Araki T, Milbrandt J. Ninjurin, A novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron 1996, 17:353-61. 10.1016/S0896-6273(00)80166-X, 8780658.
34. Kleitman N, Wood P, Johnson MI, Bunge RP. Schwann cell surfaces but not extracellular matrix organized by Schwann cells support neurite outgrowth from embryonic rat retina. J Neurosci 1988, 8:53-663.
35. Martini R. Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J Neurocytol 1994, 23:1-28. 10.1007/BF01189813, 8176415.
36. Gehrmann J, Monaco S, Kreutzberg GW. Spinal cord microglial cells and DRG satellite cells rapidly respond to transection of the rat sciatic nerve. Restor Neurol Neurosci 1991, 2:181-198.
37. Lu X, Richardson PM. Responses of macrophages in rat dorsal root ganglia following peripheral nerve injury. J Neurocytol 1993, 22:334-341. 10.1007/BF01195557, 8315414.
38. Hu P, McLachlan EM. Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 2002, 112:23-38. 10.1016/S0306-4522(02)00065-9, 12044469.
39. Smith ML, Adrian EK. On the presence of mononuclear leucocytes in dorsal root ganglia following transection of the sciatic nerve. Anat Rec 1972, 172:581-588. 10.1002/ar.1091720311, 5011947.
40. Sharp BM, Keane WF, Suh HJ, Gekker G, Tsukayama D, Peterson PK. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 1985, 117:793-795. 10.1210/endo-117-2-793, 2862014.
41. Tosk JM, Grim JR, Kinback KM, Sale EJ, Bozetti LP, Will AD. Modulation of chemiluminescence in a murine macrophage cell line by neuroendocrine hormones. Int J Immunopharmacol 1993, 15:615-620. 10.1016/0192-0561(93)90079-E, 8104166.
42. Foster JS, Moore RN. Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages. J Leuk Biol 1987, 42:171-174.
43. Hagi K, Uno K, Inaba K, Muramatsu S. Augmenting effect of opioid peptides on murine macrophage activation. J Neuroimmunol 1994, 50:71-76. 10.1016/0165-5728(94)90216-X, 7905488.
44. Apte RN, Durum SK, Oppenheim JJ. Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunol Lett 1990, 24:141-148. 10.1016/0165-2478(90)90026-M, 2162329.
45. Guan L, Townsend R, Eisenstein TK, Adler MW, Rogers TK. Both T-cells and macrophages are target of κ-opioid-induced immunosuppression. Brain Behav Immun 1994, 8:229-240. 10.1006/brbi.1994.1021, 7865894.
46. Guan L, Eisenstein TK, Adler MW, Rogers TJ. Inhibition of T cell superantigen responses following treatment with the kappaopioid agonist U50, 488H. J Neuroimmunol 1997, 75:163-168. 10.1016/S0165-5728(97)00018-0, 9143250.
47. Wybran J, Appelboom T, Famaey JP, Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol 1979, 123:1068-1070.
48. Szabo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW, Rogers TJ. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 1993, 267:703-706.